RegCell has closed a $66 million funding round combining a fully subscribed $44 million Series A financing and a $22 million non-dilutive grant from Japan’s AMED.

Read more here

Previous
RegCell Secures $66 Million of Additional Funding to Bring Nobel-Winning Immune Tolerance Science to the Clinic
Next
Regcell adds $66M to take Nobel-winning Tregs to clinic